Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024
Project: INTEGROMED
Updated at: 17-05-2024